Expanded indication would cover patients 12 years of age or younger, a population that comprises approximately one in three patients treated for hemophilia B in the United States "Approximately one ...
Moderna announced Tuesday that it has begun the rolling submission process for full approval of its COVID-19 vaccine in adults from the U.S. Food and Drug Administration. The manufacturer will ...
Confirmation of 30mg efti as optimal biological dose relevant for Immutep’s oncology pipeline and potential future Biological License Applications (BLA) Registrational TACTI-004 (KEYNOTE-F91) Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback